DK0863760T3 - Anvendelse af forbindelser med antimineralcorticoid virkning over for narkotikafvænning - Google Patents

Anvendelse af forbindelser med antimineralcorticoid virkning over for narkotikafvænning

Info

Publication number
DK0863760T3
DK0863760T3 DK96931876T DK96931876T DK0863760T3 DK 0863760 T3 DK0863760 T3 DK 0863760T3 DK 96931876 T DK96931876 T DK 96931876T DK 96931876 T DK96931876 T DK 96931876T DK 0863760 T3 DK0863760 T3 DK 0863760T3
Authority
DK
Denmark
Prior art keywords
weaning
compounds
action against
against drug
antimineral
Prior art date
Application number
DK96931876T
Other languages
English (en)
Inventor
Francis Petit
Daniel Philibert
Nick Goeders
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Application granted granted Critical
Publication of DK0863760T3 publication Critical patent/DK0863760T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Addiction (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK96931876T 1995-09-21 1996-09-19 Anvendelse af forbindelser med antimineralcorticoid virkning over for narkotikafvænning DK0863760T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9511086A FR2739029B1 (fr) 1995-09-21 1995-09-21 Nouvelle application therapeutique des composes antimineralo-corticoides
PCT/FR1996/001459 WO1997010827A1 (fr) 1995-09-21 1996-09-19 Utilisation des composes antimineralocorticoides contre le syndrome de sevrage des narcotiques

Publications (1)

Publication Number Publication Date
DK0863760T3 true DK0863760T3 (da) 2002-04-02

Family

ID=9482793

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96931876T DK0863760T3 (da) 1995-09-21 1996-09-19 Anvendelse af forbindelser med antimineralcorticoid virkning over for narkotikafvænning

Country Status (10)

Country Link
US (3) US6147066A (da)
EP (1) EP0863760B1 (da)
JP (1) JP2000513704A (da)
AT (1) ATE209920T1 (da)
DE (1) DE69617729T2 (da)
DK (1) DK0863760T3 (da)
ES (1) ES2166001T3 (da)
FR (1) FR2739029B1 (da)
PT (1) PT863760E (da)
WO (1) WO1997010827A1 (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU747956B2 (en) * 1997-10-06 2002-05-30 Board Of Trustees Of The Leland Stanford Junior University Methods for treating psychosis associated with glucocorticoid related dysfunction
EP1726307A3 (en) * 1997-10-06 2007-04-04 The Board Of Trustees Of The Leland Stanford Junior University Methods for treating psychosis associated with glucocorticoid related dysfunction
US6787531B1 (en) 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
JP2006508893A (ja) * 2002-03-15 2006-03-16 イーライ・リリー・アンド・カンパニー ステロイドホルモン核内レセプターモジュレーターとしてのジヒドロインドール−２−オン誘導体
US8445469B2 (en) * 2004-12-30 2013-05-21 Bayer Intellectual Property Gmbh 18-methyl-19-nor-17-pregn-4-ene-21,17-carbolactones, as well as pharmaceutical preparations that contain the latter
DE102004063864A1 (de) * 2004-12-30 2006-07-13 Schering Ag 18-Methyl-19-nor-17-pregn-4-en21,17-carbolactone, sowie diese enthaltende pharmazeutische Präparate
US8139039B2 (en) * 2007-07-31 2012-03-20 Kent Displays, Incorporated Selectively erasable electronic writing tablet
US8228301B2 (en) * 2007-07-31 2012-07-24 Kent Displays Incorporated Multiple color writing tablet
EP2265629B1 (en) * 2008-03-05 2015-06-24 Evestra, Inc. Bismethylene-17 carbolactones and related uses
KR101396373B1 (ko) * 2009-05-28 2014-05-19 켄트 디스플레이스 인코포레이티드 쓰기용 태블릿 정보 기록 장치
US9134561B2 (en) 2011-11-01 2015-09-15 Kent Displays Incorporated Writing tablet information recording device
US9235075B2 (en) 2012-05-22 2016-01-12 Kent Displays Incorporated Electronic display with patterned layer
US9116379B2 (en) 2012-05-22 2015-08-25 Kent Displays Incorporated Electronic display with semitransparent back layer
US10088701B2 (en) 2013-11-01 2018-10-02 Kent Displays Inc. Electronic writing device with dot pattern recognition system
US9851612B2 (en) 2014-04-02 2017-12-26 Kent Displays Inc. Liquid crystal display with identifiers
TWI646971B (zh) * 2015-12-04 2019-01-11 鄭恩哲 阻斷海洛因或嗎啡毒品中毒路徑的點滴處方及其應用
CA3049980A1 (en) * 2017-01-23 2018-07-26 Regeneron Pharmaceuticals, Inc. Hydroxysteroid 17-beta dehydrogenase 13 (hsd17b13) variants and uses thereof
CA3059348A1 (en) * 2017-04-11 2018-10-18 Regeneron Pharmaceuticals, Inc. Assays for screening activity of modulators of members of the hydroxysteroid (17-beta) dehydrogenase (hsd17b) family
AU2018348195B2 (en) 2017-10-11 2025-05-15 Regeneron Pharmaceuticals, Inc. Inhibition of HSD17B13 in the treatment of liver disease in patients expressing the PNPLA3 I148M variation
MY207352A (en) 2018-03-21 2025-02-21 Regeneron Pharma 17-hydroxysteroid dehydrogenase type 13 (hsd17b13) irna compositions and methods of use thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0533517A1 (en) * 1991-08-20 1993-03-24 Chiba Flour Milling Co. Ltd. LPS-containing anti-withdrawal agents
US5869474A (en) * 1997-05-16 1999-02-09 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Low dosage treatment for cocaine craving and withdrawal

Also Published As

Publication number Publication date
US20040242552A1 (en) 2004-12-02
DE69617729D1 (de) 2002-01-17
DE69617729T2 (de) 2002-08-08
WO1997010827A1 (fr) 1997-03-27
EP0863760B1 (fr) 2001-12-05
ATE209920T1 (de) 2001-12-15
FR2739029A1 (fr) 1997-03-28
PT863760E (pt) 2002-05-31
US6759399B1 (en) 2004-07-06
ES2166001T3 (es) 2002-04-01
EP0863760A1 (fr) 1998-09-16
FR2739029B1 (fr) 1997-11-21
JP2000513704A (ja) 2000-10-17
US6147066A (en) 2000-11-14

Similar Documents

Publication Publication Date Title
ATE209920T1 (de) Verwendung von antimineralcorticoidverbindungen gegen das drogenentzugssyndrom
PT867184E (pt) Utilizacao de tiagabina para o tratamento de desordens do sono
BR0108977A (pt) Compostos azacìclicos para uso no tratamento de doenças relaciondas com serotonina
DE69625157D1 (de) Behandlung des typ ii-deabetes mellitus mit amylinagonisten
DE69939651D1 (de) Behandlung hyperproliferativer erkrankungen
EA200100716A1 (ru) Способ профилактики рака молочной железы
PT1039900E (pt) Agentes terapeuticos
DK1030667T3 (da) Anvendelse af mirtazapin til fremstilling af et lægemiddel til behandling af sövnapnö
EA199800866A1 (ru) Способ снятия боли
EA200000693A1 (ru) Антагонисты хемокинного рецептора и способы их применения
EE9800315A (et) Meetod südamepuudulikkuse käitlemiseks endoteliini antagonistide abil
AU3308099A (en) Method for the treatment of pain, including chronic and female specific pain
ATE222768T1 (de) Ctla-8 in kombination mit g-csf oder mit g-csf und il-6, und verwendung vom ctla-8 zur behandlung von infektionen
RU98122110A (ru) Пиридил- и пиримидил-пиперазины в лечении болезней, вызываемых злоупотреблением лекарственными и/или наркотическими веществами
BR9708922A (pt) Piridil-e pirimidil-piperazinas no tratamento de doenças causadas por substâncias usadas em excesso
BR9708037A (pt) Método para o tratamento de abuso de substância
ATE306923T1 (de) Verwendung von (e)-metanicotinederivate als analgetika
DK0900085T3 (da) Behandling af overdreven aggression med olanzapin
EA200101043A1 (ru) Способ лечения неврологических или нейропсихиатрических расстройств
MX9706404A (es) Metodo para tratar deplecion de adenosina.
EA199800820A1 (ru) Способ лечения злоупотребления лекарственными средствами
AP2000002002A0 (en) Method of treatment.
UA35855A (uk) Спосіб лікування пилового бронхіту